Clinical trial
Double-Blind Naltrexone in Kleptomania
NCT00332579 · University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00332579 |
|---|---|
| Title | Double-Blind Naltrexone in Kleptomania |
| Official title | A Double-Blind, Placebo-Controlled Study of Naltrexone in Kleptomania |
| Lead sponsor | University of Minnesota, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kleptomania |
| Intervention type | Drug |
| Interventions | Naltrexone, Placebo |
| Enrollment | 25 |
| Start date | May 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Jun 1, 2006 |
| Last update posted | Jul 29, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: